EMEA-002795-PIP01-20

Table of contents

Key facts

Active substance
Respiratory syncytial virus stabilised prefusion f subunit vaccine (RSVpreF)
Therapeutic area
Vaccines
Decision number
P/0202/2021
PIP number
EMEA-002795-PIP01-20
Pharmaceutical form(s)
Powder and solvent for solution for injection
Condition(s) / indication(s)
Prevention of lower respiratory tract disease caused by respiratory syncytial virus via maternal immunisation
Route(s) of administration
Intramuscular use
Contact for public enquiries
Pfizer Europe MA EEIG

 E-mail: pip_enquiries@pfizer.com
Tel. +44 1304646607

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating